|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2006-9-4
|
|
pubmed:abstractText |
Long-term lamivudine treatment induces emergence of lamivudine-resistant hepatitis B virus (HBV) in a significant number of patients with chronic HBV infection. Rapid and quantitative methods to determine the percentage of lamivudine-resistant mutants in total HBV are important during lamivudine therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0009-8981
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
373
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
172-5
|
|
pubmed:meshHeading |
pubmed-meshheading:16814763-Child, Preschool,
pubmed-meshheading:16814763-China,
pubmed-meshheading:16814763-Cost-Benefit Analysis,
pubmed-meshheading:16814763-Drug Resistance, Viral,
pubmed-meshheading:16814763-Hepatitis B, Chronic,
pubmed-meshheading:16814763-Hepatitis B virus,
pubmed-meshheading:16814763-Humans,
pubmed-meshheading:16814763-Infant,
pubmed-meshheading:16814763-Lamivudine,
pubmed-meshheading:16814763-Mutation,
pubmed-meshheading:16814763-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16814763-Sensitivity and Specificity,
pubmed-meshheading:16814763-Sequence Analysis, DNA,
pubmed-meshheading:16814763-Time Factors
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
|
|
pubmed:affiliation |
Department of Biotechnology, Da Lian University of Technology, Da Lian 116023, Liaoning Province, China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
